
Exosome therapy is a next-generation regenerative treatment that enhances cell-to-cell communication, triggering powerful biological repair responses. These microscopic vesicles contain RNA, proteins, and growth factors that stimulate tissue regeneration, immune modulation, and anti-aging effects — without using whole cells.

Exosomes are nanosized messengers naturally secreted by stem cells. They carry signals that regulate inflammation, trigger repair mechanisms, and promote tissue regeneration. When administered therapeutically, they help reboot cellular function, especially in areas of chronic injury or degeneration.
While stem cells generate new tissue and modulate inflammation, exosomes are the communication packets stem cells use to direct healing. Exosomes can be safer and more targeted than full cell therapies, especially for systemic issues like aging, inflammation, and immune dysregulation.

Exosome therapy is ideal for:
Patients often combine exosomes with stem cells, PRP, or peptide therapy for enhanced synergy.

Exosomes have shown promise in supporting recovery from:

Regen Biologix uses only GMP-certified, third-party tested, and non-embryonic exosomes derived from healthy umbilical tissue. Administration may be IV, intramuscular, or via targeted joint injections depending on your symptoms.

Exosome therapy sessions typically last under an hour. Minimal downtime is expected, and results often begin within days to weeks. Some patients report improved energy, cognition, and mobility after just one dose.
Yes. They’re cell-free, low-risk biologics that do not carry the same regulatory concerns as stem cells. We use only rigorously tested sources.
For most patients, 1–3 treatments spaced over 1–2 months are sufficient. Chronic or advanced conditions may require more.
Absolutely. Exosomes work synergistically with EBOO, IV therapy, and peptides — and can amplify the results of stem cell treatments.
The Glucose-6-Phosphate Dehydrogenase (G6PD) Test measures enzyme activity to detect G6PD deficiency, a genetic condition that can lead to hemolytic anemia when exposed to certain foods, infections, or medications. Doctors order this test to assess unexplained anemia, jaundice, or family history of G6PD deficiency. Results help identify individuals at risk for red blood cell breakdown, guiding treatment, prevention, and safe medication use.
Specimen: Blood
Collection: Blood Draw
Also Known As: Glucose-6-Phosphate Dehydrogenase Test, G6PD Enzyme Test, G6PD Deficiency Test
Book NowThe SARS-CoV-2 Total Antibody Spike Semi-Quantitative Test detects antibodies to the COVID-19 spike protein, indicating an adaptive immune response from recent or prior infection. Vaccinated individuals may also test positive, though results should not be used to assess immunity or protection. Doctors use this blood test to confirm past exposure, but it is not designed to diagnose active infection or predict reinfection risk.
Specimen: Blood
Collection: Blood Draw
Also Known As: COVID-19 Spike Test
Book Now